VIDEO: Drop formulation effective against Demodex blepharitis

ByRichard L. Lindstrom, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Richard L. Lindstrom, MD, discusses the phase 2a Mars study results of TP-03 for the treatment of Demodex blepharitis, presented at the virtual Association for Research in Vision and Ophthalmology meeting.

The study showed statistically significant improvements in both collarette score and mite eradication.

Published by:

Sources/Disclosures

Collapse

Source: Healio Interviews

Disclosures: Lindstrom reports he is on the medical advisory board of Tarsus, the company developing TP-03.

Read more about

demodex blepharitis

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment